ClinicalTrials.gg
Not yet recruitingNCT07565896G4H-CSUpdated May 4, 2026

Gardening for Health for Cancer Survivors

An interventional study of Gardening and Nutrition Intervention in Quality of Life and Lifestyle Intervention, sponsored by University of Vermont Medical Center. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by University of Vermont Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study is testing whether a gardening and nutrition program can improve well-being in people who have had cancer. Many cancer survivors continue to experience challenges after treatment, including changes in appetite, nutrition, stress, and quality of life. Programs that combine healthy eating, physical activity, and social connection may help address these issues.

In this study, participants will take part in a 6-week, in-person program called Gardening for Health. The program includes weekly group sessions held at a garden at the University of Vermont Medical Center. Each session lasts about two hours and includes hands-on gardening activities, nutrition education, cooking demonstrations, and guided wellness practices such as mindfulness and light movement. Participants will also receive educational materials to support healthy eating and gardening at home.

The main goal of the study is to determine whether this program is feasible and acceptable for cancer survivors, meaning whether people are willing to participate, attend sessions, and find the program helpful and satisfying. The study will also explore whether participation is associated with improvements in quality of life, stress, sense of belonging, and nutrition-related behaviours.

Participants will complete questionnaires before starting the program and again after the 6-week program ends. These surveys will ask about overall health, stress levels, social connection, and lifestyle habits.

The researchers hypothesize that participation in the Gardening for Health program will be feasible and well-received by cancer survivors, and that it may lead to improvements in quality of life, reduced stress, and increased feelings of connection and well-being.

This is a single-group study, all participants receive the intervention and there is no comparison group. The results will help determine whether this type of program should be studied further in larger trials.

Read the detailed description

This is a prospective, single-center, single-arm feasibility study designed to evaluate a structured gardening and nutrition-based intervention, among adult cancer survivors. The study will enroll approximately 15 participants at the University of Vermont Cancer Center.

Cancer survivors frequently experience persistent challenges following treatment, including nutritional deficits, altered taste and appetite, reduced physical activity, psychosocial stress, and decreased quality of life. Prior research has demonstrated that multi-component lifestyle interventions, may improve dietary intake, physical functioning, and psychosocial outcomes. Building on this evidence and prior pilot work conducted at the University of Vermont Medical Center, this study evaluates an adapted, short-duration gardening and nutrition intervention tailored specifically for cancer survivors.

The intervention consists of six weekly, in-person sessions delivered over approximately six weeks in a rooftop garden setting. Each session is approximately two hours in duration and is led by a multidisciplinary team. The intervention integrates hands-on gardening activities, nutrition education, culinary instruction, and experiential components such as mindfulness, light physical activity, and nature-based engagement.

The primary objective is to evaluate feasibility and acceptability of the intervention, assessed through recruitment, retention, attendance, and participant satisfaction. Secondary objectives include assessing pre- to post-intervention changes in psychosocial outcomes, including health-related quality of life, perceived stress, and sense of belonging, as well as exploratory changes in nutrition-related knowledge and behaviors.

Participants will complete self-report assessments at baseline (prior to intervention initiation) and immediately following completion of the intervention. Qualitative feedback collected through post-intervention surveys will be analyzed to characterize participant experience and perceived impact.

This study is not powered to detect statistically significant differences in outcomes but is intended to generate preliminary data on feasibility, acceptability, and potential signals of efficacy to inform the design of future controlled trials.

02

Conditions studied

  • Quality of Life
  • Lifestyle Intervention

Keywords

  • Cancer Survivors
  • Gardening Therapy
  • Horticultural Therapy
03

In context

Lead sponsor

University of Vermont Medical Center is the lead sponsor of 43 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Self-reported current or prior diagnosis of cancer
  • Self-identifies as a cancer survivor
  • Ability to read, write, and speak English

Exclusion criteria

Exclusion Criteria:

  • Currently significantly
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Gardening and Nutrition Intervention for Cancer Survivors

    Participants will receive a six-week, in-person gardening and nutrition-based intervention delivered at the University of Vermont Medical Center rooftop garden. The program consists of six weekly sessions, each approximately two hours in duration, led by a multidisciplinary team. Participants will also receive educational materials to support gardening and healthy eating. Outcomes will be assessed using self-report questionnaires administered at baseline prior to the intervention and immediately following completion of the program.

    Behavioral: Gardening and Nutrition Intervention

Interventions

  • BehavioralGardening and Nutrition Intervention

    The intervention is a structured, six-week, in-person gardening and nutrition-based program delivered at the University of Vermont Medical Center rooftop garden. Participants will attend one session per week, each approximately two hours in duration, for a total of six sessions. The program is led by a multidisciplinary team. Each session integrates hands-on gardening activities (e.g., planting, garden maintenance, harvesting), nutrition education (e.g., dietary fiber, hydration, anti-inflammatory foods), and culinary instruction focused on preparing healthy meals. The program also incorporates experiential components such as mindfulness practices, light physical activity, and engagement with natural outdoor environments. Participants will receive educational materials, including a gardening and nutrition curriculum packet, to support continued application of skills outside of the sessions.

06

What researchers measure

Primary outcomes

  1. Acceptability of the Gardening and Nutrition Intervention

    Acceptability will be assessed using a post-intervention participant satisfaction survey. Measures will include participant-reported satisfaction with the program, perceived usefulness of the intervention components, and willingness to recommend the program to others. Responses will be summarized descriptively to evaluate overall participant satisfaction and perceived value of the intervention. Responses will be scored on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree).

    Time frame: At 6 weeks (post-intervention)

  2. Recruitment Rate

    Recruitment rate will be defined as the number of participants enrolled divided by the number of eligible participants who expressed interest in the study during the recruitment period. Unit of Measure: Percentage (%) Time Frame: During study enrollment period (up to 6 weeks)

    Time frame: At 6 weeks (post-intervention)

  3. Retention Rate

    Retention rate will be defined as the proportion of enrolled participants who complete the full intervention and post-intervention assessments (T2). Unit of Measure: Percentage (%)

    Time frame: At 6 weeks (post-intervention)

  4. Session Attendance

    Session attendance will be defined as the number of intervention sessions attended by each participant out of 6 total sessions. Attendance will be summarized as both the mean number of sessions attended and the proportion of sessions attended. Unit of Measure: Number of sessions (0-6) and Percentage (%)

    Time frame: During the 6-week intervention period

  5. Assessment Completion Rate

    Assessment completion will be defined as the proportion of participants who complete all required baseline (T1) and post-intervention (T2) questionnaires. Unit of Measure: Percentage (%)

    Time frame: At 6 weeks (post-intervention)

Secondary outcomes

  1. Change in Health-Related Quality of Life (SF-36)

    Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36). The SF-36 evaluates eight domains, including physical functioning, role limitations, emotional well-being, social functioning, pain, energy, and general health. Scores will be calculated according to standard scoring procedures, and changes from baseline to post-intervention will be analyzed. Each domain score is transformed to a 0 to 100 scale, with higher scores indicating better health-related quality of life. The outcome will be defined as the change in SF-36 domain scores from baseline (T1) to post-intervention (T2).

    Time frame: Baseline to 6 weeks

  2. Change in Perceived Stress (Perceived Stress Scale)

    Perceived stress will be assessed using the 10-item Perceived Stress Scale (PSS). The PSS measures the degree to which situations in one's life are perceived as stressful over the past month. The PSS includes 10 items rated on a Likert scale from 0 (never) to 4 (very often), with total scores ranging from 0 to 40. Total scores will be calculated, and changes from baseline to post-intervention will be evaluated. Higher scores indicate greater perceived stress (worse outcome). The outcome will be defined as the change in total PSS score from baseline (T1) to post-intervention (T2).

    Time frame: Baseline to 6 weeks

  3. Change in Sense of Belonging (General Belongingness Scale)

    Sense of belonging will be assessed using the General Belongingness Scale (GBS), which measures feelings of social inclusion and rejection. The GBS consists of 12 items rated on a Likert scale from 1 (strongly disagree) to 7 (strongly agree), with total scores ranging from 12 to 84. Total and subscale scores will be calculated, and changes from baseline to post-intervention will be analyzed. Higher scores indicate greater sense of belonging (better outcome).

    Time frame: Baseline to 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jul 2028; primary completion for Jul 2042, 168 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2026
First posted
May 4, 2026
StartEst.
Jul 2028
Primary completionEst.
Jul 2042
CompletionEst.
Jul 2042
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07565896
Lead sponsor
University of Vermont Medical Center
Responsible party
Randall F Holcombe (Director-Faculty, University of Vermont Medical Center) — Principal investigator
First posted
May 4, 2026
Start date
Jul 2028 (estimated)
Primary completion
Jul 2042 (estimated)
Completion
Jul 2042 (estimated)
Last update
May 4, 2026

Study contacts

Randall F Holcombe, MD
Contact
Randall.holcombe@med.uvm.edu
1 (802) 656-2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion